The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
Abstract
To test whether the leukotriene antagonist ONO-1078 (pranlukast) prevents asthma exacerbations during reduction of high-dose inhaled corticosteroid, we conducted a randomized, double-blind, placebo-controlled study in 79 asthma patients requiring high doses (1,500 microg/d or more) of inhaled beclomethasone dipropionate (BDI) for clinical control (duration of asthma, 11.0 +/- 3.1 yr; duration of BDI treatment, 0.5 +/- 0.3 yr; FEV1 percentage of predicted, 80.7 +/- 2.0%). After a 2-wk run-in period, the doses of BDI were halved, while the patients were assigned to receive orally ONO-1078, 450 mg twice daily, or placebo. In the placebo group FEV1 decreased by 0.33 +/- 0.20 L after 6 wk (p < 0.001). Likewise, morning and evening PEF decreased by 46 +/- 7 L/min and 18 +/- 6 L/min, respectively. By contrast these variables were sustained above baseline in the ONO-1078 group. The number of daytime and nighttime asthma symptoms and the use of beta2-agonist increased in the placebo group, whereas they remained unchanged in the ONO-1078 group. In the placebo group concentrations of serum eosinophil cationic protein and exhaled nitric oxide increased (p = 0.007 and p = 0.025, respectively), compared with no change in the ONO-1078 group. Therefore, the leukotriene antagonist ONO-1078 prevents the asthma deterioration provoked by a 6-wk reduction of the dose of inhaled BDI into half.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased nitric oxide in exhaled air of asthmatic patients
Kharitonov, S. A., Yates, D., Robbins, R. A., Barnes, P. J., Logan-Sinclair, R., & Shinebourne, E. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90931-8 · Cited by 1,436
Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma
Haahtela, T., Jarvinen, M., Kava, T., Kiviranta, K., Koskinen, S., Lehtonen, K., Nikander, K., Persson, T., Selroos, O., Sovijarvi, A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409153311103 · Cited by 743
Leukotriene E4 and granulocytic infiltration into asthmatic airways
Laitinen, L. A., Haahtela, T., Vilkka, V, Lee, T. H., & Spur, B. W. (1993) · The Lancet · doi:10.1016/0140-6736(93)91073-u · Cited by 526
Wenzel, S. E., Trudeau, J. B., Kaminsky, D. A., Cohn, J., Martin, R. J., & Westcott, J. Y. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663802 · Cited by 218
Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
Hanania, N. A., Chapman, K. R., Sturtridge, W. C., Szalai, J. P., & Kesten, S. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70254-7 · Cited by 173
Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro
Spada, C. S., Nieves, A. L., Krauss, A. H. ‐., & Woodward, D. F. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.2.183 · Cited by 156
Easy bruising as a side-effect of inhaled corticosteroids
Mak, V. H. F., Melchor, R. J., & Spiro, S. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05091068 · Cited by 109
Spence, D. P., Johnston, S. L., Calverley, P. M. A., Dhillon, P., Higgins, C. A., Ramhamadany, E., Turner, S., Winning, A. J., Winter, J. H., & Holgate, S. T. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173754 · Cited by 92
Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids
Brown, P. H., Blundell, G., Greening, A. P., & Crompton, G. K. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80268-4 · Cited by 84
Oral and Inhaled Corticosteroids Reduce Bone Formation as Shown by Plasma Osteocalcin Levels
Meeran, K. M., Hattersley, A. T., Burrin, J. M., et al. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.2.7842187 · Cited by 64
Cited by
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
The ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
Metadata
- Authors
- Tamaoki, J., Kondo, M., Sakai, N., Nakata, J., Takemura, H., Nagai, A., Takizawa, T., & Konno, K.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-04
- Volume
- 155
- Issue
- 4
- Pages
- 1235-1240
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2118378443
- Cited by
- 254
- References
- 12
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. https://app.cochat.ai/papers/10.1164/ajrccm.155.4.9105060
- The paper
- Tamaoki, J., Kondo, M., Sakai, N., Nakata, J., Takemura, H., Nagai, A., Takizawa, T., & Konno, K. (1997). Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.155.4.9105060
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.